Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer

作者: Kenji Gonda , Masahiko Shibata , Tohru Ohtake , Yoshiko Matsumoto , Kazunoshin Tachibana

DOI: 10.3892/OL.2017.6305

关键词: Myeloid-derived Suppressor CellInternal medicineOncologyInflammationCancerBreast cancerImmune systemInterleukinBiologyLymphocyteT cell

摘要: Myeloid-derived suppressor cells (MDSCs) have been identified in the majority of patients and experimental mice with tumors by their suppression T cell activation. MDSCs also reported to be associated chronic inflammation. In advanced cancer, helper (Th) balance tends shift from Th1 Th2 predominance, immune function, including cell-mediated immunity, is impaired cytokines produced cells. The present study examined correlations between MDSC levels inflammation, suppression, malnutrition, poor prognosis 155 breast cancer. preoperative recurrent cancer were significantly higher compared postoperative patients, who received chemotherapy healthy volunteers. positively correlated interleukin (IL)-6 production peripheral blood mononuclear (PBMCs), neutrophil/lymphocyte ratio C-reactive protein, negatively interferon-γ IL-12, serum concentration rapid turnover stimulation index. These divided into two groups based on MDSCs. >1.0% total PBMCs, overall survival stage IV disease was shorter other stages, <1.0% PBMCs. Thus, may function as a good prognostic indicator, particularly

参考文章(30)
Maiko Okano, Hisashi Onozawa, Hitoshi Ohto, Masahiko Shibata, Noriko Abe, Tohru Ohtake, Kenji Gonda, Mitsuhiko Yasuda, Kumiko Watanabe, Kazunoshin Tachibana, Jin Ando, Seiichi Takenoshita, [Myeloid-derived suppressor cells in patients with breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. ,vol. 39, pp. 1363- 1368 ,(2012)
Catherine E. Steding, Sung-tse Wu, Yanping Zhang, Meei-Huey Jeng, Bennett D. Elzey, Chinghai Kao, The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis. Immunology. ,vol. 133, pp. 221- 238 ,(2011) , 10.1111/J.1365-2567.2011.03429.X
Sergei Kusmartsev, Yulia Nefedova, Daniel Yoder, Dmitry I. Gabrilovich, Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. Journal of Immunology. ,vol. 172, pp. 989- 999 ,(2004) , 10.4049/JIMMUNOL.172.2.989
Bond Almand, Joseph I. Clark, Ekaterina Nikitina, James van Beynen, Nicholas R. English, Stella C. Knight, David P. Carbone, Dmitry I. Gabrilovich, Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. Journal of Immunology. ,vol. 166, pp. 678- 689 ,(2001) , 10.4049/JIMMUNOL.166.1.678
Robert L Coffman, Timothy R Mosmann, Martin A Giedlin, Holly Cherwinski, Martha W Bond, Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. Journal of Immunology. ,vol. 136, pp. 2348- 2357 ,(1986)
William E. Carson, Margaret I. Liang, Current Immunotherapeutic Strategies in Breast Cancer Surgical Oncology Clinics of North America. ,vol. 16, pp. 841- 860 ,(2007) , 10.1016/J.SOC.2007.07.008
Steven A Rosenberg, James C Yang, Nicholas P Restifo, Cancer immunotherapy: moving beyond current vaccines Nature Medicine. ,vol. 10, pp. 909- 915 ,(2004) , 10.1038/NM1100
Leisha A Emens, Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade Expert Review of Anticancer Therapy. ,vol. 12, pp. 1597- 1611 ,(2012) , 10.1586/ERA.12.147
Dmitry I. Gabrilovich, Srinivas Nagaraj, Myeloid-derived suppressor cells as regulators of the immune system Nature Reviews Immunology. ,vol. 9, pp. 162- 174 ,(2009) , 10.1038/NRI2506
Jennifer G. Reeder, Victor G. Vogel, Breast cancer risk management. Clinical Breast Cancer. ,vol. 7, pp. 833- 840 ,(2007) , 10.3816/CBC.2007.N.047